E Med Future, Inc.
EMDF · OTC
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2007 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.00 | 0.00 | 0.00 | 0.00 |
| FCF Yield | 0.00% | 0.00% | 0.00% | 5.65% |
| EV / EBITDA | 0.00 | 0.00 | 0.00 | -6.53 |
| Quality | ||||
| ROIC | 0.00% | 0.00% | 0.00% | 22.04% |
| Gross Margin | 0.00% | 0.00% | 0.00% | 65.79% |
| Cash Conversion Ratio | – | – | -0.08 | 0.16 |
| Growth | ||||
| Revenue 3-Year CAGR | 0.80% | -11.43% | -28.19% | -21.37% |
| Free Cash Flow Growth | 0.00% | -5,045.67% | 0.00% | 135.75% |
| Safety | ||||
| Net Debt / EBITDA | 0.00 | 0.00 | 0.00 | -4.54 |
| Interest Coverage | 0.00 | 0.00 | 0.00 | -2.75 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.69 |
| Cash Conversion Cycle | 0.00 | 0.00 | 0.00 | -2,581.67 |